GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (BOM:524804) » Definitions » Interest Expense

Aurobindo Pharma (BOM:524804) Interest Expense : ₹-3,226 Mil (TTM As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Aurobindo Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aurobindo Pharma's interest expense for the three months ended in Jun. 2024 was ₹ -1,110 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was ₹-3,226 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aurobindo Pharma's Operating Income for the three months ended in Jun. 2024 was ₹ 12,154 Mil. Aurobindo Pharma's Interest Expense for the three months ended in Jun. 2024 was ₹ -1,110 Mil. Aurobindo Pharma's Interest Coverage for the quarter that ended in Jun. 2024 was 10.95. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aurobindo Pharma Interest Expense Historical Data

The historical data trend for Aurobindo Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Interest Expense Chart

Aurobindo Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,416.30 -595.70 -368.40 -1,289.50 -2,680.90

Aurobindo Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -565.50 -681.80 -755.50 -678.10 -1,110.40

Aurobindo Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-3,226 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurobindo Pharma  (BOM:524804) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aurobindo Pharma's Interest Expense for the three months ended in Jun. 2024 was ₹-1,110 Mil. Its Operating Income for the three months ended in Jun. 2024 was ₹12,154 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was ₹0 Mil.

Aurobindo Pharma's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2024 )/Interest Expense (Q: Jun. 2024 )
=-1*12153.9/-1110.4
=10.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Aurobindo Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (BOM:524804) » Definitions » Interest Expense
Comparable Companies
BOM:500257 NSE:ALKEM BOM:532321 NSE:TORNTPHARM BOM:543904 BOM:524494 BOM:532331 BOM:506943 BOM:532296 BOM:540222 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AUROPHARMA:India
Address
Plot No. 1, Survey No. 83/1, Galaxy, Floors 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500032
Website
https://www.aurobindo.com
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.

Aurobindo Pharma Headlines

No Headlines